Skip to main content
. 2022 May 31;11:2021-11-2. doi: 10.7573/dic.2021-11-2

Table 1.

Review of treatments for melasma and post-inflammatory hyperpigmentation.

Treatment Mechanism of action Disadvantages Strength of Recommendation Taxonomy (SORT)
Photoprotection
  • - Reduces UV and visible light exposure, which is known to induce inflammatory responses stimulating and exacerbating pre-existing hyperpigmentation

  • - Needs to be reapplied regularly

  • - Is not an active treatment for depigmentation

B
Topical/systemic
Hydroquinone and combinations
  • - Inhibit tyrosinase activity

  • - Promote melanocyte destruction

  • - Promote degradation of melanosomes

  • - Erythema, burning, pruritis, desquamation

  • - Hydroquinone halo

  • - Ochronosis

A
Retinoid
  • - Vitamin A derivative

  • - Increase epidermal cell turnover

  • - Express anti-inflammatory properties

  • - Burning, dryness

  • - Retinoid dermatitis

  • - Risk of post-inflammatory hyperpigmentation

B
Azelaic acid
  • - Inhibit tyrosinase activity

  • - Selective antiproliferative and cytotoxic effects on melanocytes

  • - Transient erythema, irritation, pruritis, dryness, burning

B
Kojic acid
  • - Inhibit catecholase activity of tyrosinase

  • - Transient erythema

  • - Risk of contact dermatitis

B
Tranexamic acid
  • - Inhibits UV-induced plasmin activity and impairs melanogenesis

  • - Erythema, scaling, dryness

  • - Oral side effects include abdominal discomfort, bloating, headache, hypomenorrhea

  • - Risk of thrombotic events in specific populations

B
Cysteamine
  • - Inhibit tyrosinase and peroxidase

  • - Chelate metal ions required for melanin synthesis

  • - Scavenging dopaquinone

  • - Transient dryness, burning

  • - Malodorous

B
Chemical peels: glycolic acid, salicylic acid, Jessner solution, trichloroacetic acid
  • - Controlled destruction of skin layers depending on peel depth

  • - Increase keratinocyte turnover

  • - Post-inflammatory pigmentary changes

  • - Burns, erythema, irritation, desquamation

  • - Scarring

B
Laser
Ablative laser
  • - Causes controlled damage to and removes layers of skin

  • - High risk of post-inflammatory pigmentary changes

  • - Burns, erythema, pain

  • - Scarring

Not recommended
Non-ablative fractioning laser
  • - Produce coagulative damage within the dermis below the wounding threshold causing melanin extrusion

  • - Risk of post-inflammatory pigmentary changes in darker skin tones

  • - Burns, erythema, pain

  • - Requires optimization based on patient’s skin type

B
Low-fluence Q- switched laser
  • - Selectively destroys melanin pigments

  • - Risk of post-inflammatory pigmentary changes in darker skin tones

  • - Burns, erythema, pain

  • - Requires optimization based on patient’s skin type

B
Picosecond laser
  • - Produce short pulse durations with higher pulse energies leading to lower thermal effect and greater fragmentation of melanin

  • - Erythema, pain, blister formation

  • - Still has risk of post-inflammatory pigmentary changes

  • - Limited studies in skin of colour

B